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Abstract 
Background: Today’s medical devices are powered 
by batteries with a limited energy storage capacity. 
Depleted batteries have to be replaced, exposing the 
patients to the risk of adverse events. Thus, a 
method for harvesting energy inside the body is 
desirable since it would allow building devices 
without batteries. 
Methods: A miniaturized intravascular Tesla 
turbine was implanted as an arteriovenous shunt 
between the common carotid artery and external 
jugular vein of a pig. The harvested energy was 
used to power a custom-built temporary cardiac 
pacemaker. 
Results: At a flow rate of ~150 ml/min, an output 
power of 0.4 mW was measured. Successful 
ventricular pacing was performed.  
Conclusion: Harvesting energy from the circulation 
using an intravascular turbine is technically feasible 
and provides enough energy to power a cardiac 
pacemaker. 
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1. Introduction 
 
Most of today’s active medical devices are powered 
by primary batteries with limited energy storage 
capacity. Therefore, active devices such as cardiac 
pacemakers need to be replaced regularly which 
accounts for ~25% of all implantation procedures 
[1]. These repeated surgical interventions expose the 
patient to a higher risk of complications (e. g. 
infections, bleedings). In addition, surgical re-
interventions increase healthcare costs. 
Intracorporeal energy harvesting may offer an 
elegant way out. Furthermore, energy harvesting is 
also motivated by the possibility to miniaturize 
devices since the battery size dictates their volume. 
Although several concepts for intracorporeal energy 
harvesting have been proposed, few have been 
implemented in vivo [2]. Harvesting energy from 
arterial blood flow may offer a reliable and 
continuous source of energy.  
 
2. Case presentation 
 
The purpose of the present study was to test if a 
miniaturized intravascular turbine could power a 
cardiac pacemaker to pace a pig’s heart. 
 
2.1. Vascular turbine 
 
We manufactured a dedicated prototype of a Tesla 
turbine for in vivo testing (Figure 1, [3]). The 
custom-made turbine rotor consists of seven 
stainless steel discs (ø 10 mm) mounted on a shaft 
and attached to an electromagnetic generator 
(MG204, Kinetron, Netherlands). Blood flows 
between the tightly spaced discs from the outer 
diameter towards the shaft where it exits in axial 
direction. Hence, it drives the rotor by friction 
forces. The main casing of the turbine was made out 
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of polycarbonate, the in- and outlet were 3D-printed 
(Alaris 30 / VeroWhitePlus, Objet, Israel). 
 
 
Figure 1. Intravascular turbine consisting of (a) cover 
including generator stator and output terminals, (b) rotor 
shaft with generator magnets and turbine discs, (c) inlet 
connector and turbine nozzle, (d) main casing and (e) 
outlet connector 
 
2.2. Experimental setup 
 
The acute animal study was performed on a 60 kg 
domestic pig. The animal was placed in the 
recumbent position under inhalation anesthesia. We 
performed a neck-dissection and inserted two 8.5 F 
high-flow sheaths (Arrow-Flex, Arrow, USA), one 
into the left common carotid artery and one into the 
left external jugular vein. Subsequently, we 
intravenously administered one bolus of 7500 IU 
heparine. The turbine was then implanted as an 
interponate between both sheaths to create an 
arteriovenous (AV) shunt. Blood flow through the 
shunt was continuously measured using an 
ultrasonic flow sensor. Pressure drop over the 
turbine was measured by two pressure transducers.  
Ten minutes after administration of heparine, we 
measured an activated clotting time of 182 seconds 
and a platelet count of 399·109/l. We first measured 
the turbine’s power output using an electrical 
resistor to simulate a consuming device. 
Subsequently, the vascular turbine generator was 
connected to a custom-built single-chamber 
pacemaker. A bipolar pacing wire (TME 66T, 
Osypka, Germany) was connected with this 
pacemaker and sutured onto the left ventricle after 
sternotomy. The trial was approved by the Ethical 
Committee of the Veterinary Department of the 
Canton of Bern, Switzerland, and performed in 
compliance with the Guide for the Care and Use of 
Laboratory Animals. 
 
2.3. Results 
 
An output power of up to 417±102 µW at a mean 
rotor speed of 1770±237 rpm was measured. Mean 
flow rate through the system was 150.3±12.2 
ml/min, decreasing below 100 ml/min towards the 
end of the experiment when the turbine stopped 
spinning (after 16 minutes). Correspondingly, the 
pressure drop over the turbine increased from 
37.8±5.4 mmHg to ~48 mmHg (Figure 2). 
During the experiment, we successfully performed 
ventricular pacing (Figure 3). 
 
Figure 2. Pressure drop over the turbine (top) and flow 
rate through the shunt (bottom) 
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 Figure 3. ECG recorded during pacing. The asterisk 
indicates when the pacemaker was started. Prompt 
ventricular pacing was established (S). 
 
3. Discussion 
 
For the first time, energy was harvested from the 
circulation by an intravascular turbine in an in-vivo 
setting. Using the gained energy, we successfully 
paced a pig’s heart with a custom-built pacemaker. 
We harvested 0.4 mW with an energetic conversion 
efficiency estimated to 5% [3]. 
The turbine prototype is built out of materials 
exhibiting high thrombogenicity to facilitate 
prototype manufacturing. In addition, the blood 
was only slightly heparinized. Despite that, the 
turbine spun for more than a quarter of an hour. 
Towards the end of the experiment, flow rate 
decreased and pressure drop over the turbine rose 
indicating ongoing deposit and growth of thrombi 
in the turbine. This trend coincided with the 
observation that the rotor had ceased to spin after a 
certain time. In addition to the thrombogenicity of 
the materials employed in this study, it is known 
that flows with excessive shear stress can lead to 
platelet activation and subsequent thrombus 
formation in downstream regions, in particular at 
sites of low shear stress [4]. Indeed, after 
dismounting the device, clotting was observed at 
several sites on the turbine wheel (Figure 4). 
Thrombi were detected between the discs: locally at 
the outer radius of the rotor but mainly towards the 
inner radius (shaft) and by the spokes carrying the 
discs. These thrombi did impair the flow explaining 
the observed increase in flow resistance. Once the 
rotor stands still, the jet entering the rotor domain is 
not smoothly decelerated as intended but 
recirculates [3]. Such flows favor clot formation. 
Further optimization of the device is crucial in order 
to avoid thrombus formation in general. First, all 
surfaces in contact with blood should be coated 
using anti-thrombotic materials or agents. Second, 
non-contact bearing technologies may be required 
to avoid rubbing at mechanical contact points. 
Third, the geometry should be optimized further 
towards an even shear stress distribution by 
limiting the nozzle velocity and designing for 
continuously accelerated flows also in the rotating 
part of the turbine. Spokes and struts present in the 
outlet should be eliminated to avoid flow 
separation. Finally, such an energy harvester 
depends on the suitable combination of 
implantation site, turbine type, generator design 
and consuming device.  
From a medical viewpoint, the implantation of the 
device in an AV-shunt between the carotid artery 
and the jugular vein is not desired. However, the 
current prototype delivered ~40 times more energy 
than is actually required by pacemakers (10 W) [5]. 
Thus, further miniaturization of the device and 
implantation in a smaller vessel (e. g. the internal 
mammary artery) may still offer enough energy to 
power a pacemaker.  
 
Figure 4. Observation of thrombi on the rotor 
 
This first in vivo study demonstrates the concept of 
powering implantable medical devices by an 
intravascular turbine. Clinical acceptance of the 
risks associated with endovascular devices for 
energy harvesting depends on the safety and the 
efficiency, i.e. the long-term durability of such a 
device. An intra-arterial implantation using an axial 
turbine would have the advantage of simpler 
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implantation compared to the shunt configuration. 
Ultimately, percutaneous catheter based 
implantation in a small artery would offer a simple 
deployment as already established in daily clinical 
practice. 
 
4. Acknowledgments 
 
The authors would like to thank the Experimental 
Surgery Institute of the Inselspital Bern for 
providing the laboratory facilities for in vivo tests. 
We would also like to thank Jakob Schärer and Jörg 
Wagner for adapting the energy management 
system and the pacing circuit, as well as Stijn 
Vandenberghe, PhD and Christoph Huber, MD for 
support regarding the in vivo testing. 
 
5. References 
 
1. Mond HG and Proclemer A, The 11th World 
Survey of Cardiac Pacing and Implantable 
Cardioverter-Defibrillators: Calendar Year 2009–
A World Society of Arrhythmia’s Project. Pacing 
Clin. Electrophysiol., vol. 34, no. 8, pp. 1013–1027, 
2011. 
2. Pfenniger A, Jonsson M, Zurbuchen A, Koch 
VM, and Vogel R, Energy harvesting from the 
cardiovascular system, or how to get a little help 
from yourself. Ann. Biomed. Eng., vol. 41, no. 11, 
pp. 2248–2263, Nov. 2013. 
3. Pfenniger A, Vogel R, Koch VM, and Jonsson M, 
Performance Analysis of a Miniature Turbine 
Generator for Intracorporeal Energy Harvesting. 
Artif Organs, 2014 (in press). 
4. Nesbitt WS, Westein E, Tovar-Lopez FJ, et al. A 
shear gradient–dependent platelet aggregation 
mechanism drives thrombus formation. Nat. 
Med., vol. 15, no. 6, pp. 665–673, Jun. 2009. 
5. Chandrakasan AP, Verma N, and Daly DC, 
Ultralow-Power Electronics for Biomedical 
Applications. Annu. Rev. Biomed. Eng., vol. 10, 
pp. 247–274, Aug. 2008. 
 
 
 
 
Vascular Turbine Powering a Cardiac Pacemaker: an In-vivo Case Study
Exp Clin Cardiol, Volume 20, Issue 1, 2014 - Page 2003
